Related Experiment Video
Updated: Jan 16, 2026

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
Long non-coding RNA NEAT1 modulates microglial NLRP3 inflammasome activation
Bora Tastan1, Aysen Cotuk1, Burak I Arioz1
1Izmir Biomedicine and Genome Center, Izmir, Turkiye; Izmir International Biomedicine and Genome Institute, Dokuz Eylul University, Izmir, Turkiye.
Nuclear Enriched Abundant Transcript 1 (NEAT1) regulates microglial NLRP3 inflammasome activation, a key driver of neuroinflammation. NEAT1 depletion reduced pro-inflammatory cytokine release, suggesting NEAT1 as a therapeutic target for CNS disorders.
Area of Science:
- Neuroscience
- Immunology
- Molecular Biology
Background:
- Microglia are key immune cells in the central nervous system (CNS).
- Dysregulated microglial activation and NLRP3 inflammasome activation drive neuroinflammation in CNS diseases.
- Long non-coding RNAs (lncRNAs) regulate gene expression and inflammation.
Purpose of the Study:
- To investigate the role of NEAT1 in microglial NLRP3 inflammasome activation.
- To elucidate the mechanisms by which NEAT1 influences neuroinflammation.
Main Methods:
- Utilized in vitro and in vivo models, including NEAT1 knockout mice.
- Employed siRNA to deplete NEAT1 in microglia.
- Assessed NLRP3 inflammasome activation and IL-1β release.
Main Results:
- NEAT1 knockout alleviated NLRP3 inflammasome activation in vivo.
- NEAT1 expression was upregulated upon inflammasome activation in vitro.
- NEAT1 depletion attenuated inflammasome activation and IL-1β release.
- NEAT1 interacts with RNA-binding proteins to regulate inflammasome activation.
Conclusions:
- NEAT1 is a crucial regulator of microglial NLRP3 inflammasome activation.
- Targeting NEAT1 may offer therapeutic strategies for CNS disorders involving neuroinflammation.
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
Regulation of the Unfolded Protein Response

